Age-related decline in LEPR⁺ hematopoietic stem cell function

With the steady growth in the number of older individuals worldwide, understanding how aging affects tissue-specific stem cells, including the hematopoietic system, will provide valuable insights for potential therapeutic interventions and disease prevention. Several studies have shown that hematopoietic stem cells (HSCs) exhibit age-associated phenotypes as early as middle age. However, HSCs are a heterogeneous group of cells, and the question remains whether HSC subsets are differentially affected by aging. Furthermore, short-term type I interferon stimulation is critical during acute infection, and long-term exposure, as in chronic inflammation, compromises HSC repopulating function. Therefore, it is hypothesized that LEPR+ HSCs would be more susceptible to aged-associated dysfunctions due to their highly pro-inflammatory molecular programs at baseline. The study suggested that LEPR-expressing HSCs are a potential target for therapies to reverse or delay the detrimental impact of aging in the blood. It is well-appreciated that aging is associated with an increased incidence of clonal hematopoiesis, leukemic transformation, and hematological disorders, and this process starts with the HSC, the cell that gives rise to all other blood and immune cells.